Helex
helex.bio
Actively hiring
Genomics & Genetic Testing
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$3.5M
1 round on record
Latest round
$3.5M
Seed · Oct 2025 · 11 mo ago
Backers
1
pi Ventures
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Oct 2025 | $3.5M | — | yourstory.com |
Backed byfrom the funds' portfolios and accelerator catalogs
pi Ventures Similar startupsby what they do, their industry and backers
Universal access to high quality delivery platforms for developers of genomics medicines. A new path for biotechnologists.
Discover WhiteLab Genomics, where AI meets biology to revolutionize genomic medicine. Our innovative platform optimizes drug design for…
Phase Genomics: Fueling Genomic Discovery. CytoTerra® Cytogenetics, ProxiMeta™ Metagenome Deconvolution, Proximo™ Genome Scaffolding.
Ovation is a genomic data company committed to unlocking the potential of human genomic data to accelerate precision medicine.
ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs…
A genomics data science startup unifies all genomics data and connects it to life scientists through simple software solutions to drive…
News
Helex: $3.5 Million Seed Funding Closed To Advance Non-Viral Gene Therapies for Genetic Kidney Diseases
Helex, a therapeutics company pioneering targeted non-viral gene therapies for kidney diseases, has raised an oversubscribed $3.5 million Seed round led by pi Ventures, with participation from Bluehill Capital, SOSV, and a global syndicate of investors. T
Read more
Report
Helex secures $3.5m to advance kidney disease therapies
The company is developing programmable non-viral LNP therapies to deliver therapeutic cargo to kidney cells.
Read more
Report
Helex raises $3.5 million seed round led by pi Ventures to advance targeted gene therapies for kidney diseases
Helex raises $3.5 million seed round led by pi Ventures to advance targeted gene therapies for kidney diseases
Read more
Report
Helex Raises $3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases
NEW YORK, October 30, 2025--Helex secures $3.5M seed funding to develop targeted non-viral gene therapies for kidney diseases with high unmet need.
Read more
Report
Report
Report
From Friends to Founders: On a Mission to Combat Kidney Disease
With the help of a 2023 XSeed Award, Rohini Kavlakuntla, MSc, and her two graduate school buddies are advancing the work of their startup Helex to make genetic medicine accessible and affordable for those with debilitating kidney diseases.
Read more
Report
Deerfield Management Announces 2023 XSeed Award Winners
/PRNewswire/ -- Deerfield Management Company, a healthcare investment firm and Advancium Health Network, a public charity dedicated to eliminating barriers to...
Read more
Report
The women building and shaping India Company Business News
On Women's Entrepreneurship Day, here are 100 Indian women founders making a difference
Read more
Report
Show more news
Financials
Total raised
$3.5M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2025 | $3.5M | Details |